从“湿浊化疫,气机痹阻”辨治四川新型冠状病毒肺炎  

Treatment for COVID-19 in Sichuan Province Based on TCM Theory “Shizhuohuayi,Qijibizu”

作　　者：王振兴 吴永灿 安军 李培[3] 沈其霖[3] 唐健元 谢春光[1] 王飞[1] Wang Zhenxing;Wu Yongcan;An Jun;Li Pei;Shen Qilin;Tang Jianyuan;Xie Chunguang;Wang Fei(Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610075;Jiangyou Hospital of Infectious Disease,Jiangyou 621704;Mianyang Hospital of Traditional Chinese Medicine,Mianyang 621000)

机构地区：[1]成都中医药大学附属医院,成都610075 [2]江油市传染病医院,江油621704 [3]绵阳市中医医院,绵阳621000

出　　处：《中药药理与临床》2020年第3期14-17,共4页Pharmacology and Clinics of Chinese Materia Medica

基　　金：四川省科技厅2020年第一批应对新型冠状病毒科技攻关应急项目(编号:2020YFS0012、2020YFS0013)。

摘　　要：目前,新型冠状病毒肺炎(COVID-19)在全球多个国家和地区广泛流行,尚无特效药物。本文基于温病学说,结合四川省中医药救治新冠肺炎的临床实践,系统论述新冠肺炎的病因病机、传变特点和证治思路。认为新冠肺炎的病因是湿浊疫毒,基本病机为湿浊化疫、蕴毒传变、气机痹阻,临床可分为湿浊郁表、肺失清肃,湿浊中阻、痰热内蕴,疫毒闭肺、毒损肺络,湿毒蒙心、伤阴耗血,余邪滞留、气阴两伤五个阶段,并论述了相关治疗策略,这将有助于COVID-19的中医药防治。COVID-19 has swept into most countries around the world and is now officially a pandemic,but there is no specific medicine to prevent or treat it.Based on the TCM theory"Wenbing"and clinical evidence for treating COVID-19 with traditional Chinese medicine in Sichuan province,this paper systematically discussed the etiology,pathogenesis,transmission and treatment of COVID-19.It is considered that the cause of COVID-19 is"Shizhuoyidu",the basic pathogenesis is"Shizhuohuayi","Yunduchuanbian"and"Qijibizu".According to this,the COVID-19 may be divided into 5 clinical stages:"Shizhuoyubiao"and"Feishiqingsu","Shizhuozhongzu"and"Tanreneiyun","Yidubifei"and"Dusunfeiluo","Shidumengxin"and"Shangyinhaoxue","Yuxiezhiliu"and"Qiyinliangshang".This paper also discussed the relevant treatment strategies,which will be helpful to the prevention and treatment of COVID-19 with traditional Chinese medicine.

关 键 词：四川地区 新型冠状病毒 新型冠状病毒肺炎 病因病机 

分 类 号：R259[医药卫生—中西医结合]